(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine

(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine is an experimental small molecule compound with the molecular formula C17H16ClN3 and a molecular weight of approximately 297.8 g/mol. It has been referenced in chemical and pharmacological databases but is not approved for clinical use in any jurisdiction. The compound has been identified as a potential inhibitor in biochemical research, sometimes referred to as "pyrazole-based inhibitor 8b." Its mechanism of action may involve interaction with protein kinases, specifically cAMP-dependent protein kinase catalytic subunit alpha, though its precise pharmacological activity remains uncharacterized and it has not advanced into clinical trials or received regulatory approval[1][2][3][5].

Other names

(2s)-2-(4-chlorophenyl)-2-[4-(1h-pyrazol-4-yl)phenyl]ethanamine(2S)-2-(4-chlorophenyl)-2-(4-(1H-pyrazol-4-yl)phenyl)ethanamine(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine hydrochloridepyrazole-based inhibitor 8b